riamilovir , CAS No.R613182

Item Number
R613182
Grouped product items
SKUSizeAvailabilityPrice Qty
R613182-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,334.90
R613182-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$2,001.90

Basic Description

Synonyms7-methylsulfanyl-3-nitro-6H-[1,2,4]triazolo[5,1-c][1,2,4]triazin-4-one | F2HTG1MH2D | F81714 | Oprea1_193144 | Oprea1_478576 | Triazavirin | Riamilovir [INN] | RIAMILOVIR [WHO-DD] | UNII-F2HTG1MH2D | 4(1H)-one | 7-(Methylthio)-3-nitro(1,2,4)triazolo(5,1-C
Specifications & PurityMoligand™
GradeMoligand™

Associated Targets(Human)

HEK-293T (167025 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Vesicular stomatitis virus (4460 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDCK (10148 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Names and Identifiers

IUPAC Name 7-methylsulfanyl-3-nitro-6H-[1,2,4]triazolo[5,1-c][1,2,4]triazin-4-one
INCHI InChI=1S/C5H4N6O3S/c1-15-5-6-4-8-7-2(11(13)14)3(12)10(4)9-5/h1H3,(H,6,8,9)
InChi Key IDVQGNMSSHPZSJ-UHFFFAOYSA-N
Canonical SMILES CSc1nc2nnc(c(=O)n2[nH]1)[N+](=O)[O-]
Isomeric SMILES CSC1=NC2=NN=C(C(=O)N2N1)[N+](=O)[O-]
PubChem CID 3113817

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Related Documents

References

1. Karpenko I, Deev S, Kiselev O, Charushin V, Rusinov V, Ulomsky E, Deeva E, Yanvarev D, Ivanov A, Smirnova O et al..  (2010)  Antiviral properties, metabolism, and pharmacokinetics of a novel azolo-1,2,4-triazine-derived inhibitor of influenza A and B virus replication..  Antimicrob Agents Chemother,  54  (5): (2017-22).  [PMID:20194696] [10.1021/op500134e]
2. Shahab S, Sheikhi M.  (2021)  Triazavirin - Potential Inhibitor for 2019-nCoV Coronavirus M Protease: A DFT Study..  Curr Mol Med,  21  (8): (645-654).  [PMID:32436829] [10.1021/op500134e]
3. Hudecová IMJČGKMPL.  (2021)  Triazavirin might be the new hope to fight Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)..  Ceska Slov Farm,  70  (1): (18-25).  [PMID:34237949] [10.1021/op500134e]

Solution Calculators